Blincyto ( Blinatumomab 38.5mcg) Drugs Supplier in India

If you have questions, about Blincyto ( Blinatumomab 38.5mcg) Injection, please email contact@cellegenbiopharma.com or Call Cellegen Biopharma Network on +91 -8800834419 / +91 -8383028495 / +91 -9953494942 for price list of our products..

Blincyto ( Blinatumomab 38.5mcg)

Anti Cancer Medicine Manufacturer in Delhi

Enquire Now

We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.

BLINCYTO @ is a bispecific CD19-directed CD3 T-cell engager indicated forthe treatment of adultsand childrenwith:

B-cell precursoracute lymphoblastic leukemia (ALL)in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%. This indication is approved under accelerated approval based on MRDresponserate and hematological relapse-free survival. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials
Relapsed or refractory B-cell precursor acute lymphoblastic leukemia

The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.

Quick Contact

Our Products

Blincyto ( Blinatumomab 38.5mcg)

Medicine access. Made simple Request Quote Now!